initial genome sequencing analysis multiple myeloma
multiple myeloma incurable malignancy plasma cells pathogenesis poorly understood report massively parallel sequencing tumour genomes comparison matched normal dnas several new unexpected oncogenic mechanisms suggested pattern somatic mutation across data set include mutation genes involved protein translation seen nearly half patients genes involved histone methylation genes involved blood coagulation addition broader anticipated role nf-kappa b signalling indicated mutations members nf-kappa b pathway potential immediate clinical relevance activating mutations kinase braf observed % patients suggesting evaluation braf inhibitors multiple myeloma clinical trials results indicate cancer genome sequencing large collections samples will yield new insights cancer anticipated existing knowledge
